Tagrisso 40mg Tablet

Rx
Manufacturer AstraZeneca
  • Fast Delivery
  • Muslim-Friendly
  • FDA Approved
  • Secure Payment
Save: RM5,673.43   15% OFF
From RM1,340/month
  • 0% InterestNo interest on eligible instalments
  • Flexible paymentsSpread your payment across monthly instalments
  • No hidden feesClear and transparent pricing
🎟️ Available Vouchers
OCT21
RM21 OFF
Min Spend RM550.00
Valid till: 25 Oct 2026
OCT14
RM14 OFF
Min Spend RM380.00
Valid till: 25 Oct 2026
OCT7
RM7 OFF
Min Spend RM200.00
Valid till: 25 Oct 2026

Click a voucher to copy the code. Automatically applied at checkout if conditions are met.

Prescription Required

Orders placed now will be queued. A doctor will contact you on the next working day for approval.
Have questions? Chat with us on WhatsApp
Dr. Mohd Izzat Amir Bin Awang
Reviewed byDr. Mohd Izzat Amir Bin AwangDoctor of Medicine (MD), University of Mansoura - Manchester
Dr. Adeline Carol Peters
Written byDr. Adeline Carol PetersBachelor of Medicine and Bachelor of Surgery (MBBS) — Manipal Academy of Higher Education (MAHE)

Last updated:

Overview

Tagrisso 40mg Tablet contains Osimertinib (as mesilate) 40mg and is available as a tablet. It is classified as a prescription medicine and may only be obtained with a valid prescription from a registered medical practitioner.

Only product, safety and handling information is published here. Anything beyond that is explained to you directly by your doctor or pharmacist as part of your consultation.

DoctorOnCall is a licensed online pharmacy. Orders for Tagrisso 40mg Tablet are processed only after a doctor has assessed your suitability and issued a prescription, and every order is checked by a registered pharmacist before it is sent out.

Directions for Use

Take the tablet at about the same time each day, with or without food, and swallow it whole; if swallowing whole is difficult, ask your oncology team how it may be dispersed, rather than crushing or chewing it yourself.

Storage Instructions

Store below 30°C in a dry place, away from direct sunlight and out of reach of children.

Side Effects

  • Diarrhoea
  • Rash or dry skin
  • Nail changes
  • Fatigue
  • Cough
  • Low white blood cell count
  • Decreased appetite
  • Shortness of breath

Contraindications

  • Known hypersensitivity to osimertinib or any ingredient in the tablet
  • Use in pregnancy without specialist guidance, due to potential harm to the foetus

Drug / Food Interactions

  • Strong inducers of the CYP3A4 enzyme (such as rifampicin, carbamazepine, and St John’s Wort) can lower osimertinib levels and are generally avoided.
  • Osimertinib can affect the levels of some other medicines that depend on certain transporter proteins – your oncology team will review your full medicine list.
  • Medicines that prolong the QT interval should be used cautiously alongside osimertinib.
  • Inform your oncology team of all medicines and supplements you are taking.

Quick Tips

  • Contact your oncology team immediately if you develop new or worsening breathlessness, cough, or fever, as these can signal a rare but serious lung side effect.
  • Attend all scheduled heart (ECG) and blood monitoring appointments during treatment.
  • Use gentle skin and nail care, and tell your care team if rash or nail problems become uncomfortable.
  • Never stop or change the dose on your own – discuss any side effects with your oncology team first.

Ingredients / Active Ingredients

  • Osimertinib (as mesilate) 40mg

Safety Advice

Pregnancy

Not Safe

This medicine is not considered safe during pregnancy and should be avoided.

Breastfeeding

Not Advisable

Generally not recommended while breastfeeding.

Kidney

Generally Safe

Generally safe, but caution may be required in some patients.

Liver

Use With Care

Use cautiously. Liver function monitoring may be required.

Alcohol

Use With Care

Caution is advised when consuming alcohol with this medicine.

Driving

Use With Care

Use caution while driving until you know how this medicine affects you.

Frequently Asked Questions

Product Specifications

BrandAstraZeneca
ManufacturerAstraZeneca
ClassificationPrescription medicine
Ingredients / Active IngredientsOsimertinib
Pack Size30s
DosageThe usual dose is one tablet once daily, but the exact dose, duration, and any interruption or reduction is individualised and monitored by the treating oncologist based on response and side effects.
Shelf LifeRefer to the expiry date printed on the packaging.

Customer Reviews

Be the first to review this product.

Confirm Action
×

Are you sure?

×